Human monocytotropic ehrlichiosis

From WikiMD.org
Jump to navigation Jump to search

Human Monocytotropic Ehrlichiosis

Human Monocytotropic Ehrlichiosis (HME) /hjuːˌmæn mɒnəʊsaɪˈtrɒpɪk ɛrˈlɪkiəʊsɪs/ is a tick-borne disease caused by the bacterium Ehrlichia chaffeensis. It is a type of ehrlichiosis, a group of diseases that affect white blood cells.

Etymology

The term "Human Monocytotropic Ehrlichiosis" is derived from several parts: "Human" refers to the species affected by the disease; "Monocytotropic" is a combination of "mono" (single) and "cytotropic" (affecting cells), referring to the disease's effect on monocytes, a type of white blood cell; and "Ehrlichiosis" is named after Paul Ehrlich, a German physician and scientist who made significant contributions to the fields of hematology and immunology.

Symptoms

Symptoms of HME can include fever, headache, muscle aches, and fatigue. More severe cases can lead to complications such as meningitis, respiratory failure, and renal failure.

Diagnosis

Diagnosis of HME is typically made through a combination of clinical symptoms, epidemiological information, and laboratory testing. Laboratory tests can include polymerase chain reaction (PCR) testing, serology, and blood smear examination.

Treatment

Treatment for HME typically involves the use of the antibiotic doxycycline. Early treatment is crucial to prevent severe complications.

Prevention

Prevention of HME primarily involves avoiding tick bites through the use of insect repellent, wearing long sleeves and pants, and checking for ticks after being in wooded or grassy areas.

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski